default author photo

Maxime Desgrouas

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

106

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Avdoralimab (anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FORCE)

Number of pages: 26 Posted: 07 Feb 2022
La Timone University Hospital - AP-HM, affiliation not provided to SSRN, Université Côte d'Azur - Clinical Research Unit Côte d’Azur, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Innate Pharma - Innate Pharma Research Laboratories, affiliation not provided to SSRN, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, affiliation not provided to SSRN, affiliation not provided to SSRN, Université Cote d'Azur - Nice University Hospital, Aix-Marseille University - Assistance Publique - Hôpitaux de Marseille (AP-HM), Aix-Marseille University - Centre d'Immunologie de Marseille-Luminy and affiliation not provided to SSRN
Downloads 106 (659,652)

Abstract:

Loading...